"We Envision Growth Strategies Most Suited
to Your Business"
The global pharmaceutical packaging market size was valued at USD 99.94 billion in 2022 and is projected to grow from USD 105.01 billion in 2023 to USD 156.12 billion by 2030, exhibiting a CAGR of 5.83% during the forecast period. The expansion is due to an increase in packaging consumption owing to surging demand from the packaging sector.
This information is presented by Fortune Business Insights, in its report titled, “Pharmaceutical Packaging Market Size, Share & COVID-19 Impact Analysis, By Material (Plastics, Glass, Metal, Paper & Paperboard, Others), By Product Type (Bottles, Caps & Closures, Pre-fillable Inhalers, Pre-Fillable Syringes, Vials & Ampoules, Blister Packs, Bags & Pouches, Jars & Canisters, Cartridges, Others), By Drug Delivery Mode (Oral Drug Delivery Packaging, Injectable Packaging, Topical Drug Delivery Packaging, Pulmonary Drug Delivery Packaging, Transdermal Drug Delivery Packaging, Ocular Drug Delivery Packaging, Nasal Drug Delivery Packaging, Others), By Packaging Type (Primary, Secondary, and Tertiary), and Regional Forecasts, 2023-2030.”
Increasing Demand for Online Shopping Fueled the Pharmaceutical Packaging Market Growth
Due to the coronavirus pandemic, several industries were struggling, which caused a shortage of raw materials and disturbed supply chains. However, due to the importance of their operations to the community, West Pharmaceutical Services companies were spared from lockdown limitations. The rising government assistance for prescription drugs and generic medications will contribute to the market expansion.
Aptar Pharma Acquires Orbital Dry Powder Inhaler (DPI) License
The proprietary Orbital inhaler, a novel device created to deliver high payload dry powder to the lungs, was developed by clinical stage drug developer Pharmaxis. In August 2022, Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced that it has acquired the global rights to this invention. The Orbital technology enables patients to inhale powder payloads of up to 400 mg in divided doses without the need to reload, helping to fulfil a growing global need to deliver high dosages of medications, such as antibiotics, to the lungs.
Increasing Adoption of Generic Drugs in Developing Countries to Fuel Market Growth
Due to their low cost, generic pharmaceuticals are being used more frequently in poorer nations, which will increase the demand for pharmaceutical packaging. A pharmaceutical drug is considered to be generic if it contains the same chemical components, dosage, intended use, adverse effects, and route of administration as the brand-name medication. To offer medical treatments at a lesser cost, many businesses are investing in the production of generic pharmaceuticals. However, the industry expansion could be affected by an upsurge in counterfeit drugs across various regions.
To get a detailed report summary and research scope of this market, click here:
Important Business-related Announcements by Key Players to Influence Market Dynamics
Fundamental companies in the market often make crucial announcements regarding some business moves, which, in turn, affect the market either positively or negatively. Players acquire companies, launch new products, engage in partnership deals, sign contracts with government organizations, and so on.
Notable Industry Development:
List of Key Players Profiled in Report
Further Report Findings
Table of Segmentation
CAGR of 5.83% from 2023 to 2030
Value (USD Billion)
By Material, Product Type, Drug Delivery Mode, Packaging Type, and Region
By Product Type
By Drug Delivery Mode
By Packaging Type